Previous 10 | Next 10 |
Validated Nanoemulsion Capabilities Are Transformative Across Multiple Major Markets, New $1.5M Contract, New Manufacturing Facility, and Reduced Cash Burn Set Stage for Expected Strong FY 2023 Investor Call Scheduled for Tuesday May 16, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE...
Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is reporting on a consumer focus group. The f...
SOUTH EASTON, MA / ACCESSWIRE / May 10, 2023 / Often considered recession-proof, the life sciences sector faced a surprising amount of uncertainty over the past few years with up to 80% of companies saying they've been negatively impacted by the macroeconomic conditions that have shaken mark...
Additional Focus Groups Corroborate UltraShear Nano-THC Produces Equal to Much Better THC Experiences, Even from Lower THC Dosing Levels; Also, Lightning-Fast Pain Relief from Topical Use. SOUTH EASTON, MA / ACCESSWIRE / May 9, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or "Compa...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries, today provided a progre...
Company Confirms Initial Negotiations Underway with Five Different Groups for Single Statewide Exclusive Licenses for Nano-THC Products SOUTH EASTON, MA / ACCESSWIRE / April 26, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and s...
Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is making changes to its license offerings. T...
Limited Window for Exclusive 3-Year Statewide Licenses for THC Processing. PBI's UltraShear Platform Delivers Unprecedented Dosing, Speed, Stability, and Reliable Precision Without Inhalation Health Issues. SOUTH EASTON, MA / ACCESSWIRE / April 21, 2023 / Pressure BioSciences, Inc. (OTC...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences field, and Artisan Industries, a worldwide leader in providing purification an...
2023-04-18 21:21:06 ET Pressure BioSciences, Inc. (PBIO) Q4 2022 Earnings Conference Call April 18, 2023 04:30 PM ET Company Participants Richard Schumacher - President and Chief Executive Officer John Hollister - Director of Marketing and Sales Jeff Peterson - B...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...